Publication: OFF-LABEL USES OF APPROVED DRUGS A New Compromise is Needed
Open/View Files
Date
1995
Authors
Published Version
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
OFF-LABEL USES OF APPROVED DRUGS A New Compromise is Needed (1995 Third Year Paper)
Research Data
Abstract
Washington, D.C. is teeming with speculation regarding the likely effects of a new political scenery and the Republican Contract With America. As the new Congress is taking form and adjusting to a new reality, one voice stands out amid the uproar... House Speaker Newt Gingrich has an agenda, and his intentions, though not clearly spelled out, have certainly not been withheld from public discourse. One of Mr. Gingrich's strongly voiced concerns centers on structure of the FDA as it currently exists, and the effect that the entrenchment of bureaucracy has on the functioning of this agency. Mr. Gingrich frequently cites an example of a plunger-like cardiopulmonary resuscitation aid which, though invented in the United States and proven tremendously effective in Europe, is illegal and unavailable for use in this country.
Description
Other Available Sources
Keywords
Food and Drug Law, unapproved drug uses, drug prescription
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service